What is the vaccine effect on reducing transmission in the context of the SARS-CoV-2 delta variant?
Lancet Infect Dis
.
2022 Feb;22(2):152-153.
doi: 10.1016/S1473-3099(21)00690-3.
Epub 2021 Oct 29.
Author
Annelies Wilder-Smith
1
Affiliation
1
Department of Disease Control, London School of Hygiene & Tropical Medicine, London WC1E 7HT, UK. Electronic address: annelies.wilder-smith@lshtm.ac.uk.
PMID:
34756187
PMCID:
PMC8554481
DOI:
10.1016/S1473-3099(21)00690-3
No abstract available
Publication types
Comment
MeSH terms
COVID-19 Vaccines
COVID-19*
Humans
SARS-CoV-2
Vaccines*
Substances
COVID-19 Vaccines
Vaccines
Supplementary concepts
SARS-CoV-2 variants